In some countries, this medicine may only be approved for veterinary use.
In the US, Sporanox (itraconazole systemic) is a member of the drug class azole antifungals and is used to treat Aspergillosis - Aspergilloma, Blastomycosis, Candida Infections - Systemic, Candida Urinary Tract Infection, Coccidioidomycosis, Cryptococcosis, Dermatophytosis, Esophageal Candidiasis, Febrile Neutropenia, Histoplasmosis, Onychomycosis - Fingernail, Onychomycosis - Toenail, Oral Thrush, Paracoccidioidomycosis, Sporotrichosis, Tinea Capitis, Tinea Versicolor and Vaginal Yeast Infection.
US matches:
- Sporanox
- Sporanox Capsules
- Sporanox PulsePak
- Sporanox Solution
- Sporanox injection
UK matches:
- Sporanox -Pulse (SPC)
- Sporanox 10 mg/ml Oral Solution (SPC)
- Sporanox Capsules (SPC)
- Sporanox I.V. 10 mg/ml concentrate and solvent for solution for infusion (SPC)
Ingredient matches for Sporanox
Itraconazole
Itraconazole is reported as an ingredient of Sporanox in the following countries:
- Antigua & Barbuda
- Argentina
- Aruba
- Australia
- Austria
- Bahamas
- Belgium
- Bermuda
- Brazil
- Canada
- Cayman Islands
- Chile
- Colombia
- Costa Rica
- Cyprus
- Czech Republic
- Denmark
- Dominican Republic
- Ecuador
- Egypt
- El Salvador
- Ethiopia
- Finland
- France
- Greece
- Grenada
- Guatemala
- Guyana
- Honduras
- Hong Kong
- Iceland
- Indonesia
- Ireland
- Israel
- Italy
- Jamaica
- Jordan
- Lebanon
- Lithuania
- Luxembourg
- Malaysia
- Mexico
- Netherlands Antilles
- New Zealand
- Nicaragua
- Norway
- Oman
- Panama
- Peru
- Philippines
- Portugal
- Saint Lucia
- Saint Vincent & The Grenadines
- Saudi Arabia
- Serbia
- Singapore
- Slovakia
- Slovenia
- South Africa
- Spain
- Sri Lanka
- Sudan
- Suriname
- Sweden
- Switzerland
- Taiwan
- Trinidad & Tobago
- United Arab Emirates
- United Kingdom
- United States
- Venezuela
- Yemen
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Click for further information on drug naming conventions and International Nonproprietary Names.
